The limits of genetic screening: trisomy 21 after euploid preimplantation genetic testing for aneuploidy and negative noninvasive prenatal testing.
- 1Department of Obstetrics and Gynecology, Loyola University Medical Center, Maywood, IL.
Abstract
Objective
To describe a case of false-negative preimplantation genetic testing for aneuploidy (PGT-A) and noninvasive prenatal test (NIPT) resulting in a neonate born with Down Syndrome.Design
Case report.Subjects
A 40-year-old multiparous woman with in vitro fertilization pregnancy due to a history of tubal ligation presenting to an academic medical center.Exposure
Prenatal aneuploidy screening with PGT-A and cell-free DNA.Main outcome measures
PGT-A test was conducted on a day 5 blastocyst which resulted as euploid. Subsequent NIPT test was obtained at 10 weeks and reported low-risk results.Results
The patient underwent vacuum-assisted vaginal delivery of a liveborn male infant with features of Down Syndrome. Postnatal karyotype confirmed nonmosaic trisomy 21.Conclusion
PGT-A and NIPT are powerful tools used for risk reduction, but they do not eliminate risk.
Related
- Results from the VANISH study: A prospective multicenter study validating a single-nucleotide polymorphism-based noninvasive prenatal test to assess aneuploidy risk in surviving twins of vanishing twin pregnancies.
- Impact of Structured Prenatal Counseling on Decision-making and Psychological Outcomes in Indian Women with High-risk Aneuploidy Screening Results: A Prospective Cohort Study
- Efficacy of preimplantation genetic testing for aneuploidy in improving pregnancy outcome among couples with azoospermia: study protocol for a multicenter, randomized controlled trial.
- Preimplantation genetic testing for aneuploidy (PGT-A) vs. morphology-based blastocyst selection for transfer: cost-effectiveness analysis within Israel's publicly funded IVF system.
- Cumulative live birth following preimplantation genetic testing for aneuploidy versus conventional IVF/ICSI in unexplained recurrent pregnancy loss: a retrospective cohort study with intention-to-treat and per-protocol analyses
BibTeX
@article{law2026limits,
title = {{The limits of genetic screening: trisomy 21 after euploid preimplantation genetic testing for aneuploidy and negative noninvasive prenatal testing.}},
author = {Jennifer Law and Kyra Ramsey and Nicole Sprawka and Joana Perdigao},
journal = {F\&S reports},
year = {2026},
month = jul,
doi = {10.1016/j.xfre.2026.06.010},
url = {https://europepmc.org/article/MED/42903648},
note = {CC BY},
}
RIS
TY - JOUR
TI - The limits of genetic screening: trisomy 21 after euploid preimplantation genetic testing for aneuploidy and negative noninvasive prenatal testing.
AU - Jennifer Law
AU - Kyra Ramsey
AU - Nicole Sprawka
AU - Joana Perdigao
PY - 2026
DA - 2026/07/06
JO - F&S reports
DO - 10.1016/j.xfre.2026.06.010
UR - https://europepmc.org/article/MED/42903648
AB - Objective To describe a case of false-negative preimplantation genetic testing for aneuploidy (PGT-A) and noninvasive prenatal test (NIPT) resulting in a neonate born with Down Syndrome.Design Case report.Subjects A 40-year-old multiparous woman with in vitro fertilization pregnancy due to a history of tubal ligation presenting to an academic medical center.Exposure Prenatal aneuploidy screening with PGT-A and cell-free DNA.Main outcome measures PGT-A test was conducted on a day 5 blastocyst which resulted as euploid. Subsequent NIPT test was obtained at 10 weeks and reported low-risk results.Results The patient underwent vacuum-assisted vaginal delivery of a liveborn male infant with features of Down Syndrome. Postnatal karyotype confirmed nonmosaic trisomy 21.Conclusion PGT-A and NIPT are powerful tools used for risk reduction, but they do not eliminate risk.
SN - 2666-3341
ER -